CN

Frank Haykong Shum

This inventor holds 0 USPTO granted patents, plus 1 CIPO patent.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Frank Haykong Shum. Retrieved from https://idiyas.com/inventor/frank-haykong-shum

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0

ph-index = 1


Loading Chart...

Title: Frank Haykong Shum: Innovator in Analgesia

Introduction

Frank Haykong Shum is a notable inventor based in China. He has made significant contributions to the field of analgesia through his innovative methods. His work focuses on utilizing sodium channel blocking compounds to alleviate pain in mammals.

Latest Patents

Frank Haykong Shum holds a patent titled "A Method Of Producing Analgesia Using Sodium Channel Blocking Compounds Such As Tetrodotoxin, Saxitoxin And Derivatives Thereof." This invention relates to a method of producing analgesia in a mammal experiencing pain by systemically administering an effective amount of a composition comprising essentially of a sodium channel blocking compound, in a suitable pharmaceutical vehicle, to alleviate the pain. He currently has 0 patents.

Career Highlights

Frank is associated with Wex Medical Limited, where he applies his expertise in the medical field. His work is aimed at improving pain management solutions for patients.

Collaborations

Frank collaborates with his coworker, Qingbin Dong, to further advance their research and development efforts in analgesia.

Conclusion

Frank Haykong Shum is a dedicated inventor whose work in analgesia showcases the potential of sodium channel blocking compounds in pain management. His contributions are paving the way for future innovations in the medical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…